CISTRON BIOTECHNOLOGY INC
3, 1999-08-04
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CISTRON BIOTECHNOLOGY INC, SC 13D, 1999-08-04
Next: CISTRON BIOTECHNOLOGY INC, 4, 1999-08-04






                                                  ------------------------------
                                                           OMB APPROVAL
                                                  ------------------------------
                                                  OMB Number
                                                  Expires:
                                                  Estimated average burden
                                                  hours per response ....... 0.5
                                                  ------------------------------

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 3

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)
- --------------------------------------------------------------------------------
1.   Name and Address of Reporting Person*

     Glasser                          Harvey                Wm.
- --------------------------------------------------------------------------------
   (Last)                            (First)              (Middle)

     1020 Vallejo Street
- --------------------------------------------------------------------------------
                                    (Street)

     San Francisco                          CA                   94133
- --------------------------------------------------------------------------------
   (City)                            (State)                (Zip)

- --------------------------------------------------------------------------------
2.   Date of Event Requiring Statement (Month/Day/Year)

     April 20, 1999
- --------------------------------------------------------------------------------
3.   IRS Identification Number of Reporting Person, (Voluntary)


- --------------------------------------------------------------------------------
4.   Issuer Name and Ticker or Trading Symbol

     Cistron Biotechnology, Inc    NASDAQ: CIST
- --------------------------------------------------------------------------------
5.   Relationship of Reporting Person(s) to Issuer
     (Check all applicable)

     [_]  Director                             [X]  10% Owner
     [_]  Officer (give title below)           [_]  Other (specify below)


- --------------------------------------------------------------------------------
6.   If Amendment, Date of Original (Month/Day/Year)


- --------------------------------------------------------------------------------
7.   Individual or Joint/Group Filing  (Check Applicable Line)

     [X]  Form Filed by One Reporting Person

     [_]  Form Filed by More than One Reporting Person


<TABLE>

====================================================================================================================================
                                       Table I -- Non-Derivative Securities Beneficially Owned
====================================================================================================================================

<CAPTION>

                                                                 3. Ownership Form:
                                      2. Amount of Securities       Direct (D) or
1. Title of Security                     Beneficially Owned         Indirect (I)       4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                            (Instr. 4)                 (Instr. 5)            (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                                        <C>                           <C>
Common Stock                               5,244,906                     D
====================================================================================================================================
</TABLE>


Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.

*    If the Form is filed by more than one reporting  person,  see  Instruction
     5(b)(v).



                                                                          (Over)
                                                                  SEC 1473(7-96)

FORM 3 (continued)
<TABLE>

              Table II -- Derivative Securities Beneficially Owned
         (e.g., puts, calls, warrants, options, convertible securities)

================================================================================
<CAPTION>


                                                                                                        5. Owner-
                                                    3. Title and Amount of Securities                      ship
                                                       Underlying Derivative Security                      Form of
                         2. Date Exercisable           (Instr. 4)                                          Derivative
                            and Expiration Date     ---------------------------------    4. Conver-        Security:
                            (Month/Day/Year)                               Amount           sion or        Direct      6. Nature of
                         ----------------------                            or               Exercise       (D) or         Indirect
                         Date       Expira-                                Number           Price of       Indirect       Beneficial
1. Title of Derivative   Exer-      tion                                   of               Derivative     (I)            Ownership
   Security (Instr. 4)   cisable    Date            Title                  Shares           Security       (Instr. 5)     (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                      <C>       <C>              <C>                    <C>           <C>            <C>            <C>


- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>


Explanation of Responses:




/s/ Harvey Wm. Glasser                                       7/19/99
- ---------------------------------------------        ---------------------------
      **Signature of Reporting Person                          Date



**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations.

     See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:  File three copies of this Form, one of which must be manually signed.
       If space provided is insufficient, See Instruction 6 for procedure.


Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
WA992020.123/2+
                                                                          Page 2
                                                                  SEC 1473(7-96)

                             Joint Filer Information


Name:

Address:


I.R.S. Number:

Designated Filer:

Issuer & Ticker Symbol:

Date of Event
  Requiring Statement


Signature:
                           ----------------------------





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission